Meclofenamate elicits a nephropreventing effect in a rat model of ischemic acute kidney injury by suppressing indoxyl sulfate production and restoring renal organic anion transporters

References

• Cruz DN Ricci Z Ronco C Clinical review: RIFLE and AKIN – time for reappraisal Crit Care 2009 13 3 211 219 19638179
   PubMed Web of Science ®Google Scholar
• Murray PT Devarajan P Levey AS A framework and key research questions in AKI diagnosis and staging in different environments Clin J Am Soc Nephrol 2008 3 3 864 868 18287251
   PubMed Web of Science ®Google Scholar
• Vanholder R De Smet R Glorieux G Review on uremic toxins: classification, concentration, and interindividual variability Kidney Int 2003 63 5 1934 1943 12675874
   PubMed Web of Science ®Google Scholar
• Neirynck N1 Vanholder R Schepers E An update on uremic toxins Int Urol Nephrol 2013 45 1 139 150 22893494
   PubMed Web of Science ®Google Scholar
• Niwa T Indoxyl sulfate is a nephro-vascular toxin J Ren Nutr 2010 20 Suppl 5 S2 S6 20797565
   PubMed Web of Science ®Google Scholar
• Niwa T Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120 Ther Apher Dial 2011 15 2 120 124 21426500
   PubMed Web of Science ®Google Scholar
• Vincent JL Acute kidney injury, acute lung injury and septic shock: how does mortality compare? Contrib Nephrol 2011 174 71 77 21921611
   PubMed Web of Science ®Google Scholar
• Liu KD Matthay MA Advances in critical care for the nephrologist: acute lung injury/ARDS Clin J Am Soc Nephrol 2008 3 2 578 586 18199848
   PubMed Web of Science ®Google Scholar
• May CN Calzavacca P Ishikawa K Novel targets for sepsis-induced kidney injury: the glomerular arterioles and the sympathetic nervous system Exp Physiol 2012 97 11 1168 1177 22689445
   PubMed Web of Science ®Google Scholar
• Herget-Rosenthal S Glorieux G Jankowski J Jankowski V Uremic toxins in acute kidney injury Semin Dial 2009 22 4 445 448 19708999
   PubMed Web of Science ®Google Scholar
• Saito H Toxico-pharmacological perspective of the Nrf2-Keap1 defense system against oxidative stress in kidney diseases Biochem Pharmacol 2013 85 7 865 872 23333765
   PubMed Web of Science ®Google Scholar
• Bagshaw SM Hoste EA Braam B Cardiorenal syndrome type 3: pathophysiologic and epidemiologic considerations Contrib Nephrol 2013 182 137 157 23689660
   PubMed Web of Science ®Google Scholar
• Vanholder R Schepers E Pletinck A Neirynck N Glorieux G An update on protein-bound uremic retention solutes J Ren Nutr 2012 22 1 90 94 22200422
   PubMed Web of Science ®Google Scholar
• Chiang CK Tanaka T Nangaku M Dysregulated oxygen metabolism of the kidney by uremic toxins: review J Ren Nutr 2012 22 1 77 80 22200419
   PubMed Web of Science ®Google Scholar
• Banoglu E King RS Sulfation of indoxyl by human and rat aryl (phenol) sulfotransferases to form indoxyl sulfate Eur J Drug Metab Pharmacokinet 2002 27 2 135 140 12064372
   PubMed Web of Science ®Google Scholar
• Banoglu E Jha GG King RS Hepatic microsomal metabolism of indole to indoxyl, a precursor of indoxyl sulfate Eur J Drug Metab Pharmacokinet 2001 26 4 235 240 11808865
   PubMed Web of Science ®Google Scholar
• Enomoto A Takeda M Tojo A Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity J Am Soc Nephrol 2002 13 7 1711 1720 12089366
   PubMed Web of Science ®Google Scholar
• Miyazaki T Ise M Hirata M Indoxyl sulfate stimulates renal synthesis of transforming growth factor-beta 1 and progression of renal failure Kidney Int Suppl 1997 63 S211 S214 9407462
   PubMed Web of Science ®Google Scholar
• Iwata K Watanabe H Morisaki T Involvement of indoxyl sulfate in renal and central nervous system toxicities during cisplatin-induced acute renal failure Pharm Res 2007 24 4 662 671 17318420
   PubMed Web of Science ®Google Scholar
• Morisaki T Matsuzaki T Yokoo K Regulation of renal organic ion transporters in cisplatin-induced acute kidney injury and uremia in rats Pharm Res 2008 25 11 2526 2533 18612803
   PubMed Web of Science ®Google Scholar
• Kusumoto M Kamobayashi H Sato D Alleviation of cisplatin-induced acute kidney injury using phytochemical polyphenols is accompanied by reduced accumulation of indoxyl sulfate in rats Clin Exp Nephrol 2011 15 6 820 830 21858734
   PubMed Web of Science ®Google Scholar
• Matsuzaki T Watanabe H Yoshitome K Downregulation of organic anion transporters in rat kidney under ischemia/reperfusion-induced acute renal failure Kidney Int 2007 71 6 539 547 17245393
   PubMed Web of Science ®Google Scholar
• Schneider R Meusel M Renker S Low-dose indomethacin after ischemic acute kidney injury prevents downregulation of Oat1/3 and improves renal outcome Am J Physiol Renal Physiol 2009 297 6 F1614 F1621 19794109
   PubMed Web of Science ®Google Scholar
• Wong CC Williamson G Inhibition of hydroxycinnamic acid sulfation by flavonoids and their conjugated metabolites Biofactors 2013 39 6 644 651 24038617
   PubMed Web of Science ®Google Scholar
• Kimura Y Ito H Ohnishi R Hatano T Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity Food Chem Toxicol 2010 48 1 429 435 19883715
   PubMed Web of Science ®Google Scholar
• Li C Lim SC Kim J Choi JS Effects of myricetin, an anticancer compound, on the bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats Eur J Drug Metab Pharmacokinet 2011 36 3 175 182 21442417
   PubMed Web of Science ®Google Scholar
• Eaton EA Walle UK Lewis AJ Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase. Potential role in drug metabolism and chemoprevention Drug Metab Dispos 1996 24 2 232 237 8742236
   PubMed Web of Science ®Google Scholar
• De Santi C Pietrabissa A Spisni R Mosca F Pacifici GM Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids Xenobiotica 2000 30 9 857 866 11055264
   PubMed Web of Science ®Google Scholar
• King RS Ghosh AA Wu J Inhibition of human phenol and estrogen sulfotransferase by certain non-steroidal anti-inflammatory agents Curr Drug Metab 2006 7 7 745 753 17073578
   PubMed Web of Science ®Google Scholar
• Vietri M De Santi C Pietrabissa A Fenamates and the potent inhibition of human liver phenol sulphotransferase Xenobiotica 2000 30 2 111 116 10718119
   PubMed Web of Science ®Google Scholar
• Sauvant C Holzinger H Gekle M Prostaglandin E2 inhibits its own renal transport by downregulation of organic anion transporters rOAT1 and rOAT3 J Am Soc Nephrol 2006 17 1 46 53 16338963
   PubMed Web of Science ®Google Scholar
• Myers SI Wang L Liu F Bartula LL Suprarenal aortic clamping and reperfusion decreases medullary and cortical blood flow by decreased endogenous renal nitric oxide and PGE2 synthesis J Vasc Surg 2005 42 3 524 531 16171601
   PubMed Web of Science ®Google Scholar
• Tokuyama H Hayashi K Matsuda H Role of nitric oxide and prostaglandin E2 in acute renal hypoperfusion Nephrology (Carlton) 2003 8 2 65 71 15012736
   PubMed Web of Science ®Google Scholar
• Tokuyama H Hayashi K Matsuda H Stenosis-dependent role of nitric oxide and prostaglandins in chronic renal ischemia Am J Physiol Renal Physiol 2002 282 5 F859 F865 11934696
   PubMed Web of Science ®Google Scholar